Investigation of potential breath biomarkers for the early diagnosis of breast cancer using gas chromatography-mass spectrometry

Clinica Chimica Acta

Volumn 436, Issue , 2014, Pages 59-67

  Li, Jie ^a   Peng, Yulan ^b   Liu, Yong ^a   Li, Wenwen ^a   Jin, Ya ^b   Tang, Zhentao ^a   Duan, Yixiang ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Biomarkers; Breast cancer; Breath analysis; Early diagnosis; Noninvasive diagnosis

Indexed keywords

ALDEHYDE DERIVATIVE; HEPTYL ALDEHYDE; HEXANAL; NONANAL; OCTANAL; TUMOR MARKER; UNCLASSIFIED DRUG; ALDEHYDES; TUMOR MARKERS, BIOLOGICAL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; BREATH ANALYSIS; BREATH SAMPLER; CANCER DIAGNOSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MASS FRAGMENTOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; SAMPLER; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; BREAST NEOPLASMS; BREATH TESTS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; METHODS;

ALDEHYDES; BREAST NEOPLASMS; BREATH TESTS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901330795     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.04.030     Document Type: Article

References (45)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Maruvada P., Wang W., Wagner P.D., Srivastava S. Biomarkers in molecular medicine: cancer detection and diagnosis. Biotechniques 2005, 5:9-16.
3. Hwa H.-L., Kuo W.-H., Chang L.-Y., et al. Prediction of breast cancer and lymph node metastatic status with tumour markers using logistic regression models. J Eval Clin Pract 2008, 14:275-280.
4. Lam T., Nabi G. Potential of urinary biomarkers in early bladder cancer diagnosis. Expert Rev Anticancer Ther 2007, 7:1105-1115.
5. Ludwig J.A., Weinstein J.N. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 2005, 5:845-856.
6. Modak A.S. Breath biomarkers for personalized medicine. Pers Med 2010, 7:643-653.
7. Amann A., Smith D., Scientific W. Breath analysis for clinical diagnosis and therapeutic monitoring: World Scientific Singapore 2005.
8. Phillips M. Breath tests in medicine. Sci Am 1992, 267:74-79.
9. Miekisch W., Schubert J.K., Noeldge-Schomburg G.F.E. Diagnostic potential of breath analysis-focus on volatile organic compounds. Clin Chim Acta 2004, 347:25-39.
10. Anh D.T.V., Olthuis W., Bergveld P. A hydrogen peroxide sensor for exhaled breath measurement. Sens Actuators B 2005, 111-112:494-499.
11. Szulejko J.E., McCulloch M., Jackson J., McKee D.L., Walker J.C., Solouki T. Evidence for cancer biomarkers in exhaled breath. IEEE Sensors J 2010, 10:185-210.
12. Buszewski B., Kesy M., Ligor T., Amann A. Human exhaled air analytics: biomarkers of diseases. Biomed Chromatogr 2007, 21:553-566.
13. Kasapovic J., Pejic S., Todorovic A., Stojiljkovic V., Pajovic S.B. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages. Cell Biochem Funct 2008, 26:723-730.
14. Mense S.M., Remotti F., Bhan A., et al. Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol Appl Pharmacol 2008, 232:78-85.
15. Ambrosone C.B. Oxidants and antioxidants in breast cancer. Antioxid Redox Signal 2000, 2:903-917.
16. Returner H., Kessler W., Einsele H., et al. Ethanol promotes oxygen-radical attack on proteins, but not on lipids. Drug Metab Rev 1989, 20:219-232.
17. Kessler W., Remmer H. Generation of volatile hydrocarbons from amino acids and proteins by an iron/ascorbate YGSH system. Biochem Pharmacol 1990, 39:1347-1351.
18. Clemens M.R., Remmer H., Waller H.D. Phenylhydrazine-induced lipid peroxidation of red blood cells in vitro and in vivo: monitoring by the production of volatile hydrocarbons. Biochem Pharmacol 1984, 33:1715-1718.
19. Phillips M., Cataneo R.N., Ditkoff B.A., et al. Volatile markers of breast cancer in the breath. Breast J 2003, 9:184-191.
20. Phillips M., Cataneo R., Ditkoff B., et al. Prediction of breast cancer using volatile biomarkers in the breath. Breast Cancer Res Treat 2006, 99:19-21.
21. Phillips M., Beatty J.D., Cataneo R.N., et al. Rapid Point-of-care breath test for biomarkers of breast cancer and abnormal mammograms. PLoS One 2014, 9:e90226.
22. Li J., Peng Y., Duan Y. Diagnosis of breast cancer based on breath analysis: an emerging method. Crit Rev Oncol Hematol 2013, 87:28-40.
23. Poli D., Goldoni M., Corradi M., et al. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS. J Chromatogr B 2010, 878:2643-2651.
24. Fuchs P., Loeseken C., Schubert J.K., Miekisch W. Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer 2010, 126:2663-2670.
25. Deng C., Zhang X., Li N. Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 808:269-277.
26. Ebeler S.E., Clifford A.J., Shibamoto T. Quantitative analysis by gas chromatography of volatile carbonyl compounds in expired air from mice and human. J Chromatogr B 1997, 702:211-215.
27. Shahidi F. Headspace volatile aldehydes as indicators of lipid oxidation in foods. Headspace Analysis of Foods and Flavors 2001, 113-123. Springer, US. R. Rouseff, K. Cadwallader (Eds.).
28. Reinheckel T., Noack H., Lorenz S., Wiswedel I., Augustin W. Comparison of protein oxidation and aldehyde formation during oxidative stress in isolated mitochondria. Free Radic Res 1998, 29:297-305.
29. Mazzone P.J. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J Thorac Oncol 2008, 3:774-780. [710.1097/JTO.1090b1013e31817c37439].
30. Deng C., Zhang X. A simple, rapid and sensitive method for determination of aldehydes in human blood by gas chromatography/mass spectrometry and solid-phase microextraction with on-fiber derivatization. Rapid Commun Mass Spectrom 2004, 18:1715-1720.
31. Yazdanpanah M., Luo X., Lau R., Greenberg M., Fisher L.J., Lehotay D.C. Cytotoxic aldehydes as possible markers for childhood cancer. Free Radic Biol Med 1997, 23:870-878.
32. Španěl P., Smith D., Holland T.A., Singary W.A., Elder J.B. Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom 1999, 13:1354-1359.
33. Phillips M., Gleeson K., Hughes J.M.B., et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet 1999, 353:1930-1933.
34. Zhou M., Liu Y., Duan Y. Breath biomarkers in diagnosis of pulmonary diseases. Clin Chim Acta 2012, 413:1770-1780.
35. Peng G., Hakim M., Broza Y.Y., et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer 2010, 103:542-551.
36. Righettoni M., Schmid A., Amann A., Pratsinis S.E. Correlations between blood glucose and breath components from portable gas sensors and PTR-TOF-MS. J Breath Res 2013, 7:037110.
37. Svensson S., Laerstad M., Broo K., Olin A.-C. Determination of aldehydes in human breath by on-fibre derivatization, solid-phase microextraction and GC-MS. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 860:86-91.
38. Wilson H.K., Monster A.C. New technologies in the use of exhaled breath analysis for biological monitoring. Occup Environ Med 1999, 56:753-757.
39. Righettoni M., Tricoli A., Gass S., Schmid A., Amann A., Pratsinis S.E. Breath acetone monitoring by portable Si:WO3 gas sensors. Anal Chim Acta 2012, 738:69-75.
40. Phillips M., Herrera J., Krishnan S., Zain M., Greenberg J., Cataneo R.N. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B 1999, 729:75-88.
41. Herrera A.C.S.A., Panis C., Victorino V.J., et al. Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients. Cancer Immunol Immunother 2012, 61:2193-2201.
42. Amann A., Poupart G., Telser S., Ledochowski M., Schmid A., Mechtcheriakov S. Applications of breath gas analysis in medicine. Int J Mass Spectrom 2004, 239:227-233.
43. Miekisch W., Schubert J.K. From highly sophisticated analytical techniques to life-saving diagnostics: technical developments in breath analysis. TrAC Trends Anal Chem 2006, 25:665-673.
44. Kabat G., Jones J., Olson N., et al. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. Cancer Causes Control 2010, 21:821-828.
45. Hartmann L.C., Sellers T.A., Frost M.H., et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005, 353:229-237.